Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Teva
Dow
McKesson
Daiichi Sankyo
Citi
Cipla
Julphar
AstraZeneca
Novartis

Generated: August 20, 2017

DrugPatentWatch Database Preview

HYDREA Drug Profile

« Back to Dashboard

Which patents cover Hydrea, and what generic Hydrea alternatives are available?

Hydrea is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in HYDREA is hydroxyurea. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.

Summary for Tradename: HYDREA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list89
Clinical Trials: see list5
Patent Applications: see list155
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDREA at DailyMed

Pharmacology for Tradename: HYDREA

Ingredient-typeUrea
Drug ClassAntimetabolite
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
HYDREA
hydroxyurea
CAPSULE;ORAL016295-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HYDREA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
HYDREA
hydroxyurea
CAPSULE;ORAL016295-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Argus Health
Healthtrust
Cipla
McKesson
Moodys
Merck
Colorcon
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot